Skip to main content

Perinatal Management of Hepatic Adenomas.

Publication ,  Journal Article
Nocita, MA; Brady, CW; Kuller, JA; Gatta, LA
Published in: Obstet Gynecol Surv
December 2024

IMPORTANCE: With a strong association between hepatic adenomas and estrogen established, understanding the risks, evaluation, and perinatal management of hepatic adenomas is necessary for obstetric clinicians. OBJECTIVE: The aim of this study is to review the preconception counseling, perinatal management, and postpartum care of hepatic adenomas. EVIDENCE ACQUISITION: A literature review identified relevant research, review articles, textbook chapters, databases, and societal guidelines. RESULTS: Hepatic adenomas require individualized recommendations based on their prepregnancy size and evolution over pregnancy. Hepatic adenomas measuring greater than 5 cm are associated with a significantly increased risk during pregnancy including rupture. Ideally, optimal management of hepatic adenoma includes accurate diagnosis, discontinuation of estrogen-containing contraception, and surgical resection of large masses prior to conception. Patients should undergo serial surveillance of the adenoma during the antenatal and postpartum periods, with surgical intervention as indicated with multidisciplinary planning. CONCLUSIONS AND RELEVANCE: An individualized approach is necessary when managing hepatic adenomas in the patient who is pregnant or intends pregnancy. More contemporary data are required to guide management and patient counseling.

Duke Scholars

Published In

Obstet Gynecol Surv

DOI

EISSN

1533-9866

Publication Date

December 2024

Volume

79

Issue

12

Start / End Page

735 / 740

Location

United States

Related Subject Headings

  • Pregnancy Complications, Neoplastic
  • Pregnancy
  • Perinatal Care
  • Obstetrics & Reproductive Medicine
  • Liver Neoplasms
  • Humans
  • Female
  • Adenoma, Liver Cell
  • Adenoma
  • 4204 Midwifery
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nocita, M. A., Brady, C. W., Kuller, J. A., & Gatta, L. A. (2024). Perinatal Management of Hepatic Adenomas. Obstet Gynecol Surv, 79(12), 735–740. https://doi.org/10.1097/OGX.0000000000001331
Nocita, Megan A., Carla W. Brady, Jeffrey A. Kuller, and Luke A. Gatta. “Perinatal Management of Hepatic Adenomas.Obstet Gynecol Surv 79, no. 12 (December 2024): 735–40. https://doi.org/10.1097/OGX.0000000000001331.
Nocita MA, Brady CW, Kuller JA, Gatta LA. Perinatal Management of Hepatic Adenomas. Obstet Gynecol Surv. 2024 Dec;79(12):735–40.
Nocita, Megan A., et al. “Perinatal Management of Hepatic Adenomas.Obstet Gynecol Surv, vol. 79, no. 12, Dec. 2024, pp. 735–40. Pubmed, doi:10.1097/OGX.0000000000001331.
Nocita MA, Brady CW, Kuller JA, Gatta LA. Perinatal Management of Hepatic Adenomas. Obstet Gynecol Surv. 2024 Dec;79(12):735–740.

Published In

Obstet Gynecol Surv

DOI

EISSN

1533-9866

Publication Date

December 2024

Volume

79

Issue

12

Start / End Page

735 / 740

Location

United States

Related Subject Headings

  • Pregnancy Complications, Neoplastic
  • Pregnancy
  • Perinatal Care
  • Obstetrics & Reproductive Medicine
  • Liver Neoplasms
  • Humans
  • Female
  • Adenoma, Liver Cell
  • Adenoma
  • 4204 Midwifery